mounjaro tirzepatide news What's better for weight loss, or Ozempic? New study provides answer Lilly, Novo Fight Weight Loss

Data demonstrated a consistent level of IOP lowering across all baseline IOPs and throughout the 90-day efficacy period

2023 Sep 6;12(18):5796

Mohaimenul Islam, University at Buffalo, United States Reviewed by Zaiyong Zheng, Southwest Medical University, China Santiago Sierra Castillo, CES University, Colombia Updates Copyright 2026 Wu, Lee, Huang, Chang and Lin

The PSPeptides COA interpretation guide walks through how to evaluate a Certificate of Analysis when comparing vendors directly

A review describing the GLP-1 class as a new frontier in alcohol use disorder summarizes findings that these drugs can lower alcohol consumption and cravings in some studies